M/S FINECURE PHARMACEUTICALS LIMITED

FOREIGN

Total Medicines

Active

Dosage Forms

Country

Kenya (1)

Registration Status

Registered 1

Dosage Forms

EACH 5 ML RECONSTITUTED SUSPENSION CONTAINS: CEFUROXIME AXETIL USP EQ. TO CEFUROXIME……………. 125 MG CLAVULANATE POTASSIUM USP EQ. TO CLAVULANIC ACID…….31.25 MG 1

Therapeutic Classes

GENERIC/BIOSIMILARS 1

Local Agents / Applicants

M/S FINECURE... 1

Registered Medicines

Showing 1 of 1

Search all

Product	Form / Strength	Country	Reg. Number	Status
FUROXICLAV 156.25 SUSPENSION CEFUROXIME WITH POTASSIUM CLAVULANATE FOR ORAL SUSPENSION (156.25 MG/5 ML): CEFUROXIME AXETIL USP EQ. TO CEFUROXIME AND CLAVULANATE POTASSIUM USP EQ. TO CLAVULANIC ACID	EACH 5 ML RECONSTITUTED SUSPENSION CONTAINS: CEFUROXIME AXETIL USP EQ. TO CEFUROXIME……………. 125 MG CLAVULANATE POTASSIUM USP EQ. TO CLAVULANIC ACID…….31.25 MG	Kenya	H2022/CTD6386/12563	Registered

Product

Country

Status

FUROXICLAV 156.25 SUSPENSION

CEFUROXIME WITH POTASSIUM CLAVULANATE FOR ORAL SUSPENSION (156.25 MG/5 ML): CEFUROXIME AXETIL USP EQ. TO CEFUROXIME AND CLAVULANATE POTASSIUM USP EQ. TO CLAVULANIC ACID

Kenya

Registered